QPPV.COM KNOWLEDGE ASSESSMENT

Metformin: Discovery, Development, Safety and Pharmacovigilance โ€” Knowledge Assessment

Test your understanding of the concepts covered by Metformin: Discovery, Development, Safety and Pharmacovigilance.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Which set of details is most useful when following up a suspected adverse pregnancy outcome after metformin exposure?
Question 2 of 10 Which statement best describes the QPPV's system-level role in relation to a suspected metformin-associated lactic-acidosis case?
Question 3 of 10 Which statement best reflects current understanding of metformin's molecular action?
Question 4 of 10 A safety communication is being prepared for a pregnancy exposure in a UK-authorised metformin product. Which wording principle is most appropriate?
Question 5 of 10 A patient taking metformin, insulin, and a sulfonylurea experiences hypoglycaemia during poor food intake. Which approach to attribution is most appropriate?
Question 6 of 10 A patient asks whether a historical recall of certain extended-release metformin lots proves that metformin as an active substance causes cancer. What is the best response?
Question 7 of 10 A quality complaint reports a suspected tablet defect but no suspected adverse reaction. Which statement best reflects the relationship between the complaint and ICSR processing?
Question 8 of 10 A patient with stable chronic kidney impairment develops severe dehydration and acute kidney injury while taking metformin. Which safety interpretation is most appropriate?
Question 9 of 10 A reviewer cites a cohort association between metformin and hospitalisation with acidosis at eGFR below 30 as evidence that metformin is safe to use below the contraindicated threshold if monitored. Which response is most accurate?
Question 10 of 10 What does ADOPT most directly contribute to understanding metformin treatment?

Select an answer to continue.

QPPV.com